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Abstract
The astrocyte cystine/glutamate antiporter (system xc) contributes substantially to the excitotoxic neuronal cell death
facilitated by glucose deprivation. The purpose of this study was to determine the mechanism by which this occurred. Using
pure astrocyte cultures, as well as, mixed cortical cell cultures containing both neurons and astrocytes, we found that neither
an enhancement in system xc expression nor activity underlies the excitotoxic effects of aglycemia. In addition, using three
separate bioassays, we demonstrate no change in the ability of glucose-deprived astrocytes—either cultured alone or with
neurons—to remove glutamate from the extracellular space. Instead, we demonstrate that glucose-deprived cultures are
2 to 3 times more sensitive to the killing effects of glutamate or N-methyl-D-aspartate when compared with their glucosecontaining controls. Hence, our results are consistent with the weak excitotoxic hypothesis such that a bioenergetic
deficiency, which is measureable in our mixed but not astrocyte cultures, allows normally innocuous concentrations of
glutamate to become excitotoxic. Adding to the burgeoning literature detailing the contribution of astrocytes to neuronal
injury, we conclude that under our experimental paradigm, a cytotoxic, co-operative interaction between energy deprivation
and glutamate release from astrocyte system xc mediates aglycemic neuronal cell death.
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Introduction
Hypoglycemia is a common and serious medical emergency that arises as a complication in patients attempting
to tightly regulate glucose levels with insulin and is the
limiting factor in the development of strategies that aim
to maintain normoglycemia in diabetics (Lincoln et al.,
1996; Lacherade et al., 2009). Hypoglycemia is also a
complication in neonates and in patients with insulin-producing tumors (Anderson et al., 1967; de Herder, 2004)
and occurs as a consequence of brain ischemia.
Idiopathic, diabetic, and reactive hypoglycemia, (i.e.,
low blood glucose concentrations of <3.9 mM) can produce a variety of cognitive symptoms resulting from an
inadequate supply of glucose to the brain. Owing to the
fact that there is a linear relationship between blood and
brain glucose levels (Choi et al., 2001), a large drop in
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blood glucose concentration (<2.0 mM) renders the brain
aglycemic, which can result in a severe impairment of
cognition, seizures, unconsciousness, and coma. If glucose levels are not restored within 30 min time, death of
vulnerable cortical and hippocampal neurons also ensue
(Suh et al., 2003; Auer, 2004).
Despite being initiated by glucose deprivation (GD),
both in vitro and in vivo investigations showed that hypoglycemic neuronal cell death is not a direct result of
energy failure but instead is mediated by glutamate
excitotoxicity (Engelsen et al., 1986; Linden et al., 1987;
Monyer et al., 1989; Papagapiou and Auer, 1990;
Jackman et al., 2012). Adding to this understanding, we
recently described system xc—a transporter that exports
L-glutamate in exchange for L-cystine (Bannai,
1984b)—in astrocytes as a source of glutamate required
for the initiation of non-cell autonomous neuronal injury
following GD in vitro (Jackman et al., 2012). The precise
mechanism by which injury is facilitated by astrocyte
system xc was not ascertained therein and thus is the
focus of this study.
Maintenance of extracellular glutamate concentrations
within a narrow physiological range involves control of
its release as well as its uptake, both of which are eﬃciently managed by glutamate transporters expressed predominantly by astrocytes. Pertinently, numerous studies
demonstrate that system xc is an important contributor
to the ambient extracellular glutamate levels that bathe
the central nervous system (CNS) in vivo (Jabaudon et al.,
1999; Warr et al., 1999; Baker et al., 2002a, 2002b;
Melendez et al., 2005; Augustin et al., 2007;
Featherstone and Shippy, 2008; De Bundel et al., 2011;
Massie et al., 2011) with maximal transporter activity
estimated to theoretically increase extracellular glutamate
by 0.6 mM/s (Warr et al., 1999; Cavelier et al., 2005).
Conversely, nearly 90% of glutamate is removed by
astrocytic Excitatory Amino Acid Transporters 1
(EAAT1) and 2 (EAAT2; Rothstein et al., 1996;
Anderson and Swanson, 2000). Thus, excitotoxic processes subsequent to GD in our system could result via
the enhancement of astrocytic glutamate release from
system xc, by a reduction in astrocyte cellular reuptake
or by a combination of both. Hence, the overall purpose
of this study was to investigate whether changes in system
xc expression or alterations in glutamate handling
following GD occur(s) and contributes to aglycemic neuronal cell death.

Materials and Methods
Animals
This study was conducted in accordance with the National
Institutes of Health guidelines for the use of experimental
animals and was approved by the Institutional Animal
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Care and Use Committee at both The University of
Connecticut Health Center and Syracuse University.
Time-pregnant CD1 mice were obtained from Charles
River Laboratories (Wilmington, MA).

Cell Culture
Media stock (MS): L-glutamine-free modiﬁed Eagle’s
medium (Earl’s salt; MediaTech, Herndon, VA) supplemented with L-glutamine, glucose, and sodium bicarbonate to a ﬁnal concentration of 2.0, 25.7, and 28.2 mM,
respectively; Glial plating media: MS containing 10%
heat-inactivated fetal bovine serum (Hyclone, Logan,
UT) and 10% heat-inactivated calf serum (CS; Hyclone,
Logan, UT), 10 ng/ml epidermal growth factor
(Invitrogen, Carlsbad, CA), and 50 IU penicillin/50 mg/ml
streptomycin (GibcoÕ , Life Technologies, Grand Island,
NY); Glial/mixed culture maintenance media: MS containing 10% CS and 50 IU penicillin/50 mg/ml streptomycin;
Neuronal plating media: MS containing 5% CS and 5%
heat-inactivated bovine growth serum (Hyclone, Logan,
UT) and 50 IU penicillin/50 mg/ml streptomycin (GibcoÕ ,
Life Technologies, Grand Island, NY); Neuronal maintenance media: neurobasal medium (GibcoÕ , Life
Technologies, Grand Island, NY) containing 2 mM
L-glutamine, 1 B27 supplement (GibcoÕ , Life
Technologies, Grand Island, NY), and 50 IU penicillin/
50 mg/ml streptomycin (GibcoÕ , Life Technologies,
Grand Island, NY); HEPES-controlled salt solution
(HCSS): 120 mM NaCl, 5.4 mM KCl, 0.8 mM MgCl2,
1.8 CaCl2, 15 mM glucose, 20 mM HEPES, 10 mM
NaOH, 10 mM glycine, and 0.001% phenol red;
Glucose-free balanced salt solution (BSS0): 116 mM
NaCl, 5.4 mM KCl, 0.8 mM MgCl2, 1 mM NaH2PO4,
26.2 mM NaHCO3, 1.8 mM CaCl2, 0.01 mM glycine,
and 2 mM L-glutamine. Unless otherwise indicated,
BSS contained 1  MEM amino acids (Life
Technologies, Grand Island, NY).
Primary astrocytes were cultured from cortices of
postnatal Day 1 to 3 CD1 mouse pups as described
previously (Trackey et al., 2001; Uliasz et al., 2012).
Cortices were dissected, pooled, and cells dissociated
by trypsin digestion (0.025%, 15 min, 37 C). Cells were
plated 400 ml/well in glial plating medium (two hemispheres/10 ml/plate; Falcon Primaria 24-well plates;
BD Biosciences, Lincoln Park, NJ). Once conﬂuent,
astrocyte monolayers were treated with 8 mM
b-D-cytosine arabinofuranoside (AraC) once for 4 to 7
days to reduce the number of microglia. Cells were then
placed in maintenance media (vide supra), which
was replaced once per week until experimentation.
Puriﬁed astrocyte cultures were generated by removing
residual microglia by treating monolayers with 50
to 75 mM L-leucine methyl ester for 30 to 90 min,
1 day prior to experimentation (Hamby et al., 2006;
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Uliasz et al., 2012). Cultures were used for experimentation at 35 days in vitro.
Primary neuronal cultures were derived from dissociated cortical cells of embryonic Day 15 CD1 mouse
fetuses. Following dissection and dissociation by trypsin
digestion (vide supra), cells were diluted to a concentration of 106 cells/ml of neuronal plating medium and then
plated into polyethyleneimine coated 24-well plates
(CostarÕ , Corning, NY). Four hr later, the medium was
exchanged to neuronal maintenance medium. Two days
later, cultures were treated with 1 mM AraC once for
2 days to prevent glial cell growth. The medium was
partially replenished (1/2 volume exchange) at DIV 4.
Experiments were performed on puriﬁed neuronal cultures after 6 days in vitro.
Mixed cortical cell cultures containing an approximate
50:50 neuron-to-astrocyte ratio were prepared by culturing dissociated cells from embryonic Day 15 CD1 mouse
fetuses on to a conﬂuent layer of microglia-depleted
astrocytes in neuronal plating media. The plating
medium was partially replaced (2/3 exchange) with maintenance medium at Days 5 and 9 in vitro. At Day 7,
cultures were treated with 8 mM of AraC once to
prevent microglial cell growth. Two days prior to experimentation, mixed cortical cell cultures were placed
into MS (vide supra). Experiments were performed at
14 days in vitro. All cultures were maintained at
37 C in a humidiﬁed 6.0% CO2, 21% O2-containing
incubator.

Glucose Deprivation
Mixed cortical cultures and astrocyte cultures were
deprived of glucose by thorough washing with and into
BSS0. Glucose (ﬁnal concentration ¼ 10 mM) was immediately added to parallel cultures to serve as controls and
added back to experimental conditions as indicated in
each ﬁgure legend. In the MK-801 (R&D System,
Rockford, IL) or LY367385 (R&D System, Rockford,
IL) experiments, MK-801 was made as a 10 mM stock
solution in H2O, and LY367385 was made as a 50 mM
stock solution in 0.1 NaOH. The drugs or their corresponding vehicle were either given at the initiation of GD
or spiked into desire groups at the times indicated in each
ﬁgure legend.

Measurement of Neuronal Cell Death
Cell death was quantitatively determined by the spectrophotometric measurement of lactate dehydrogenase
(LDH) found in the cell culture medium as described in
detail previously (Uliasz and Hewett, 2000). Data are
expressed as a percentage of total neuronal LDH activity
(deﬁned as 100% cell death) determined by exposing
parallel cultures to 200 mM of N-methyl-D-aspartate
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(NMDA) for 20 to 24 hr. As cultured astrocytes do
not express NMDA receptors (Backus et al., 1989;
Chan et al., 1990; B. Fogal and S.J. Hewett, unpublished
data) and have previously been shown to survive up
to 8 hr of GD (Jackman et al., 2012), LDH measurements can be used as a speciﬁc measure of neuron cell
death.

Quantitative Real-Time Polymerase Chain Reaction
Total RNA was isolated and ﬁrst-strand cDNA synthesized as previously described (Uliasz et al., 2012).
Quantitative real-time polymerase chain reaction
(qPCR) was performed using mouse-speciﬁc primer
pairs (Taqman Gene Expression Assays, Applied
Biosystems: xCT [Mm00442530_m1] and b-actin
[Mm01205647_g1]) per manufacturer’s instructions.
Reactions were run in the Eppendorf Real-Time PCR
System and relative quantiﬁcation performed using the
comparative cycle threshold method (CT), where CT
values of xCT were normalized to b-actin CT values from
the same sample and then compared with a calibrator
sample CT value (control group, cultures kept in BSS10)
to determine the relative fold increase in mRNA. b-actin
CT values are unaﬀected by GD.

Radiolabeled L-Cystine and D-Aspartate Uptake
14
System
xc-speciﬁc
C-L-cystine
(PerkinElmer;
Waltham, MA) and system XAG-mediated 3H-D-aspartate (PerkinElmer; Waltham, MA) uptake was performed
as previously described (Fogal et al., 2007). Cultures were
washed into HCSS (3  750 ml) and allowed to equilibrate
for 10 min (25 C). For cystine uptake, cells were incubated in HCSS containing 3 mM 14C-L-cystine (1 mCi/
ml), 27 mM unlabeled cystine, 1 mM D-aspartate, and
0.5 mM acivicin (Enzo Life Sciences; Farmingdale, NY).
D-aspartate and acivicin were included in the uptake
buﬀer to block system XAG and g-glutamyltranspeptidase, respectively. Uptake was terminated after 30 min by
washing in ice-cold PBS (3  750 ml). For D-aspartate
uptake, cells were incubated in HCSS containing
0.1 mCi/ml 3H-D-aspartate and 50 mM unlabeled D-aspartate (25 C) for 5 min and uptake terminated by washing
cells with an ice-cold Naþ-free choline stop buﬀer
containing in mM: 116 choline chloride, 0.8 MgSO4, 1
KH2PO4, 10 HEPES, 5 KOH, 10 glucose, 0.9 CaCl2,
and 5 nonradioactive D-aspartate.
Cells were lysed with warm 0.5% SDS and accumulated radioactivity estimated using a liquid scintillation
counter. Readings of counts per minute from experimental conditions were corrected back to the original volume
of lysate, and the picomoles of cystine and aspartate
transported per minute were calculated as described
(Fogal et al., 2007).
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Toxicity Bioassay
Puriﬁed astrocyte cultures were washed thoroughly into
BSS containing or lacking 10 mM glucose. Sixty, 75, 90,
or 105 min before the end of a 6-hr incubation period,
glutamate—75 mM ﬁnal well concentration—was spiked
into the wells after which the supernatant was collected
and transferred via 3/4 exchange to highly enriched
murine neuronal cultures. Six hr later, neuronal cell
death was quantiﬁed by measurement of the LDH
released into the cell culture medium. Data are expressed
as a percentage of total neuronal cell death facilitated by
adding 200 mM glutamate to parallel neuronal cultures
1 day prior to experimentation. We demonstrated previously that the toxicity of the supernatant correlated
with the glutamate-buﬀering capacity of astrocytes
(Sen et al., 2011). Of note, glucose, to a ﬁnal concentration of 10 mM, was added to all pooled media prior to its
addition to neurons to prevent any confound associated
with GD.
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transferred to a 37 C, normoxic (21%), 6% CO2 containing incubator overnight. Neuronal cell death was determined by the LDH assay, and data were expressed as a
percentage of total neuronal LDH activity obtained by
exposing parallel cultures to 200 mM of NMDA for 20 to
24 hr (deﬁned as 100% neuronal cell death).

Statistical Analysis
All statistical analyses were performed using GraphPad
Prism (Version 6.0.1, GraphPad Software, Inc.) as
described in each ﬁgure legend. As percentage data and
normalized data are by nature nonnormally distributed,
such data were ﬁrst transformed via arcsin square root or
1  log (Y), respectively, before analysis. Values of zero
or less were set at 1  1020 before transformation. In the
case of qPCR, statistics were performed on the geometric
means of 2CT values. In all experiments, data were
expressed as mean þ SEM. Signiﬁcance was assessed at
p < .05.

Measurement of Glutamate
Two hundred microliters of supernatant harvested from
the toxicity bioassay experiment (vide supra) were analyzed for glutamate concentration in the media via phenylisothiocyanate derivatization, high-performance liquid
chromatography (HPLC) separation using a HypersilODS reverse-phase column, and ultraviolet detection at
254 nm as described in (Fogal et al., 2007).

Measurement of Adenosine Triphosphate
Adenosine triphosphate (ATP) levels were determined
using the ATP Determination Kit (Molecular ProbeTM,
Invitrogen; Eugene, OR) per manufacturer’s instruction.
Culture wells were aspirated dry and the plate quick
frozen on dry ice. After 5 min, plates were incubated at
37 C for 10 min. One milliliter or 250 ml of a 1  Cell
Culture Lysis Reagent (Promega; Madison, WI) was
added into each well of a 6-well or 24-well plate, respectively. Plates were gently shaken for 5 min. Cell lysates
were collected, and intracellular ATP levels were measured and normalized to protein levels (BCA Assay;
PierceTM, Pierce Biotechnology, Rockford, IL). When
necessary, samples were diluted so that values fell
within the linear range of the assay (0–1 mM).

Excitotoxicity Assays
Mixed cortical cultures were deprived of glucose or incubated with glucose for the times indicated before being
washed and exposed to either 25 mM NMDA or 100 mM
glutamate in HCSS at room temperature. After 10 min,
the exposure solution was washed away and replaced by
MS supplemented with 10 mM glycine. The cells were

Results
In conﬁrmation of prior literature from our own laboratory as well as that from others, we demonstrate that
removal of glucose from the cell culture medium of
mixed neuronal/astrocyte cortical cell cultures results in
a time-dependent (Figure 1(a)) and NMDA receptormediated excitotoxic neuronal cell death (Figure 1(b);
Monyer and Choi, 1988; Monyer et al., 1989; Jackman
et al., 2012). That system xc activity contributes to death
is illustrated by the fact that removal of amino acids
(Figure 2(a))—speciﬁcally cystine (Jackman et al.,
2012)—from the glucose-free medium reduced aglycemic
neuronal injury, whereas addition of cystine back to the
medium lacking amino acids results in signiﬁcant neuronal cell death (Figure 2(a)). Furthermore, addition of
the dual mGluR1/system xc antagonist LY367385
ameliorates aglycemic neuronal cell death, while the
mGluR1-speciﬁc antagonist, YM 298198, shows no protection (Figure 2(b); Jackman et al., 2012). While neurons
and astrocytes both express functional system xc in our
culture system (Jackman et al., 2010), we recently
described astrocytic system xc as the main source of glutamate required for the initiation of neuronal injury following GD in vitro (Jackman et al., 2012).
Cellular stress results in transcriptional adaptive
increases in the substrate-speciﬁc light chain of system
xc, xCT, and a subsequent increase in cystine uptake
(Bannai, 1984a; Ishii et al., 1992; Miura et al., 1992;
Ishii et al., 2000; Sasaki et al., 2002; Sato et al., 2004).
Hence, whether xCT mRNA levels was altered following
aglycemia in pure astrocyte cultures or in mixed cortical
cultures containing both astrocytes and neurons was
ascertained using quantitative PCR analysis. In both
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Figure 1. Aglycemic neuronal cell death is time-dependent and is
blocked by NMDA receptor antagonism. (a) Mixed cortical cultures
were washed into BSS containing (0 hr) or lacking 10 mM glucose
for the times indicated, after which neuronal cell death was
determined via measurement of LDH release. An asterisk (*) represents values significantly different from control (0 hr) as assessed
by one-way ANOVA followed by Dunnett’s post hoc test (n ¼ 8–10
cultures from three separate experiments). (b) Mixed cortical
cultures were washed into BSS lacking or containing 10 mM glucose
(0 hr)  MK-801 (10 mM). Neuronal cell death was determined via
measurement of LDH release. An asterisk (*) denotes a significant
within-group difference, whereas a pound sign (#) denotes a
significant between-group difference as determined by two-way
ANOVA followed by Bonferroni’s post hoc test for multiple
comparisons (n ¼ 6 cultures from three separate experiments).
NMDA ¼ N-methyl-D-aspartate; BSS ¼ balanced salt solution;
LDH ¼ lactate dehydrogenase; ANOVA ¼ analysis of variance.

astrocyte and mixed cortical cell cultures, a signiﬁcant
increase in xCT mRNA occurs following 8 hr of GD
but not earlier (Figure 3(a) and (b)). Because signiﬁcant
and nearly maximal cell death occurs by this time point
(Figure 1), we ﬁnd it unlikely that a change in system xc
expression underlies its neurotoxic eﬀect. In keeping with
this, actinomycin D (10 mg/ml), when given at the onset of
GD, fails to prevent aglycemic neuronal cell death
(Figure 4(a)), demonstrating no requirement for transcription. Death is similarly unaﬀected by cycloheximide
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Figure 2. System xc contributes to aglycemic neuronal cell
death. (a) Mixed cortical cultures washed into BSS0 containing (GD)
or lacking (-AA) MEM amino acids save for supplementation with
100 mM L-cystine (þ Cyss). (b) Mixed cultures were deprived of
glucose (GD) in the absence or presence of the dual system xc/
mGluR1 inhibitor, LY367385 (LY; 50 mM) or the selective mGluR1
antagonist, YM298190 (YM; 10 mM). Neuronal cell death was
determined 8 hr later via measurement of LDH release. An asterisk
(*) equals values different from control (cultures in BSS10), while a
pound sign (#) represents a significant diminution from GD-induced
injury as determined by one-way ANOVA followed by Bonferroni’s
post hoc test for multiple comparisons (n ¼ 10–11 from three
independent experiments).
GD ¼ glucose
deprivation;
LDH ¼ lactate
dehydrogenase;
BSS ¼ balanced salt solution; ANOVA ¼ analysis of variance.

(1 mg/ml), indicating no need for protein synthesis
(Figure 4(b)).
To ascertain whether system xc activity was enhanced
by GD, we measured 14C-L-cystine uptake in the mixed
cortical cell cultures. No change in activity is noted over
the time-course of GD studied (Figure 5(a)), suggesting
increased glutamate extrusion via system xc does not
underlie its neurotoxic eﬀect. As maintenance of extracellular glutamate concentrations involves control of release
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Figure 3. Aglycemia regulates xCT mRNA levels in a timedependent manner. (a) Purified astrocyte cultures or (b) mixed
cortical cultures containing both astrocytes and neurons were
deprived of glucose for the times indicated and changes in xCT
mRNA assessed via qPCR. An asterisks (*) represent values that
are significantly different from 0 hr (i.e., glucose-containing control)
as determined by one-way ANOVA followed by a Dunnett’s post
hoc test for multiple comparison (n ¼ 4 from four separate
experiments each).
qPCR ¼ quantitative real-time polymerase chain reaction;
ANOVA ¼ analysis of variance.

Figure 4. Macromolecular synthesis inhibitors do not prevent
aglycemic neuronal cell death. Mixed cortical cultures were
rendered aglycemic in the presence or absence of (a) the
transcriptional inhibitor actinomycin D (ACT D; 10 mg/ml; n ¼ 6–10
from five separate experiments) or (b) the protein synthesis
inhibitor cycloheximide (CHX; 1 mg/ml; n ¼ 12 from three separate
experiments). Six and 8 hr later, the amount of neuronal cell death
was assessed. (a, b) Two-way ANOVA revealed no significant
between-group differences in either paradigm.
ANOVA ¼ analysis of variance.

as well as uptake, we next investigated whether aglycemic-mediated alterations in glutamate removal occurred.
We ﬁnd no signiﬁcant diﬀerence in 3H-D-aspartate
uptake—a measure of EAAT activity as veriﬁed by the
ability of D,L-threo-b-benzyloxyaspartate to completely
suppress the uptake—between control mixed cultures and
those that were deprived of glucose (Figure 5(b)). Also,
glucose-deprived astrocytes retain the ability to remove
exogenously added glutamate just as eﬀectively as control
astrocytes (Figure 6(a)). Finally, glutamate-containing
media removed from glucose-deprived astrocytes is
equally as toxic to pure neuronal cultures as that from
glucose-containing medium at every time point assessed
(Figure 6(b)). Therefore, overstimulation of neuronal
excitatory amino receptors via enhancement of the

extracellular glutamate concentration cannot account
for the excitotoxic insult mediated by system xc under
aglycemic conditions.
Consequently, we set out to test whether the weak
excitotoxic hypothesis (Albin and Greenamyre,
1992)—which posits that bioenergetic deﬁciencies
enhance the toxic eﬀect of glutamate—might explain
the results described earlier. Following GD in vitro,
rapid ATP depletion has been reported to occur in
neurons with astrocytes being more resistant (Choi
et al., 2008). Likewise, we ﬁnd that aglycemic astrocytes
maintain cellular ATP levels (Figure 7(a)), whereas the
concentration of ATP in mixed cortical cultures is signiﬁcantly and severely depressed when glucose was removed
from the media (Figure 7(b)). These changes are not
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Figure 5. Aglycemia does not significantly alter cystine or aspartate uptake. (a) Mixed cortical cultures were deprived of glucose
for the times indicated, then incubated with buffer containing
14
C-L-cystine for 30 min to measure system xc activity. Data are
expressed as mean þ SEM 14C-L-cystine uptake in pmol/min/mg
protein. Aglycemia had no significant effect on radiolabeled cystine
uptake as determined by one-way ANOVA followed by a Dunnett’s
post hoc test (n ¼ 6 from two separate experiments). (b) Mixed
cortical cultures were deprived of glucose for the times indicated,
then 3H-D-aspartate was added for 5 min to measure EAAT activity.
D,L-threo-b-benzyloxyaspartate (500 mM) was used to confirm
uptake via EAATs (n ¼ 6 from five separate experiments). Data are
expressed as mean þ SEM 3H-D-aspartate uptake in pmol/min/mg
protein. (a, b) ANOVA revealed no significant within-group
differences (compared with 0 hr) in each paradigm.
TBOA ¼ D,L-threo-b-benzyloxyaspartatemethionine;
EAAT ¼ Excitatory Amino Acid Transporter; ANOVA ¼ analysis
of variance.

simply due to neuronal loss from the mixed cultures
because the addition of MK-801 and LY367385, which
protects the neurons from aglycemia-induced death
(Figures 1(b) and 2(b)), does not rescue the culture
ATP levels (Figure 7(c)).
To investigate whether aglycemic cortical neurons
would show an enhanced susceptibility to excitotoxic
insult, we deprived mixed cultures of glucose for increasing periods of time (2.5 to 4.5 hr) after which glutamate
(100 mM ﬁnal well concentration) was added for 10 min.
Compared with cells maintained in glucose-containing
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Figure 6. Aglycemic astrocytes are still capable of glutamate
uptake. Purified astrocyte cultures were glucose deprived
( Glucose) or washed into BSS containing glucose (þGlucose;
10 mM) for 6 hr before glutamate (final concentration ¼ 75 mM) was
added to cultures. At the times indicated after addition, bathing
medium was removed and like groups pooled. (a) HPLC analysis
was used to measure remaining glutamate in an aliquot of the
pooled media. Data are expressed as percentage of initial glutamate
concentration (75 mM; n ¼ 3–6 from three separate experiments).
(b) The pooled medium was then added to pure neuronal cultures
(2/3 exchange). Six hr later, neuronal cell death was assessed.
(n ¼ 10 from five separate experiments). (a, b) No significant
between-group differences were found using two-way ANOVA.
HPLC ¼ high-performance liquid chromatography; BSS ¼ balanced
salt solution; ANOVA ¼ analysis of variance.

medium, results show that glutamate kills signiﬁcantly
more neurons when the cultures are glucose deprived at
every time point tested (Figure 8(a)). Likewise, neurons in
glucose-deprived cultures are more susceptible to death
than control cultures when exposed to equimolar concentrations of NMDA (Figure 8(b)).
Finally, to study the optimal therapeutic time window
for rescue, mixed cortical cultures were deprived of
glucose for a total of 8 hr and either MK-801, to
block NMDA receptors (Figure 9(a)), or LY367385
(Figure 9(b)), to mitigate glutamate release from system
xc, was added to parallel cultures at 1- to 2-hr intervals
postexperimental onset. The percentage of the dying
neuronal population that could be rescued depended on
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Figure 7. Aglycemia decreases ATP levels in cortical neurons but
not astrocytes. (a) Purified cortical astrocyte cultures (n ¼ 7–8 from
two independent experiments) or (b) mixed cortical cultures
(n ¼ 3–4 from one experiment) were placed in medium containing
glucose for 6 hr (0) or deprived of glucose for the times indicated,
after which ATP levels were measured as described in methods.
(c) Mixed cortical cultures were washed into BSS lacking
( Glucose, black bars) or containing 10 mM glucose (þGlucose,
white bars)  MK-801 (MK; 10 mM) or LY367385 (LY; 50 mM). Six hr
later, ATP levels were measured (n ¼ 6 from two independent
experiments). Data are expressed as mean þ SEM. Individual values
are normalized to each well’s protein levels. (a, b) An asterisk (*)
indicates a significant difference from 0 hr as determined by oneway ANOVA followed by a Dunnett’s post hoc test for multiple
comparison. (c) An asterisk indicates a significant between-group
difference as determined by two-way ANOVA followed by
Bonferroni’s post hoc test for multiple comparisons.
ATP ¼ adenosine triphosphate; BSS ¼ balanced salt solution;
ANOVA ¼ analysis of variance.
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Figure 8. Glucose-deprived mixed cultures are more susceptible
to the toxic effects of glutamate and NMDA. Mixed cortical
cultures (a) were deprived of glucose for the times indicated
followed by exposure to 100 mM glutamate (n ¼ 6 from three
separate experiments) or (b) were deprived of glucose for 2.25 hr
followed by exposure to increasing concentrations of NMDA (n ¼ 6
from three separate experiments). Ten min later, cultures were
washed free of glutamate or NMDA and placed back into a glucosecontaining medium. The percentage of neuronal cell death was
assessed 20 to 24 hr later by measurement of LDH. An asterisk (*)
indicates a significant between-group difference assessed by twoway ANOVA followed by a Bonferroni’s post hoc test for multiple
comparison.
NMDA ¼ N-methyl-D-aspartate; LDH ¼ lactate dehydrogenase;
ANOVA ¼ analysis of variance.

the time interval between washout of glucose and addition of the pharmacological agents. When compared
with 8 hr of GD alone, MK-801 is able to completely
block aglycemic neuronal injury when given up to 3 hr
after the start of GD, and it is still signiﬁcantly eﬀective
when addition is delayed for 5 hr (Figure 9(a)). In contrast, maximal protection for LY367385 occurs at 1 hr,
though signiﬁcant protection is also demonstrated up
to 5 hr (Figure 9(b)). No protection is observed with
either compound if its administration is delayed by 7 hr
(Figure 9(a) and (b)).
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Figure 9. Delayed pharmacological rescue of aglycemic neuronal
injury in mixed cortical cultures. Mixed cortical cultures were
deprived of glucose for a total 8 hr (GD). (a) MK-801 (10 mM) or
(b) LY367385 (50 mM) were added at the times indicated after the
initiation of GD. The percentage of neuronal cell death was
assessed via the LDH assay. An asterisks (*) indicates a significant
difference from GD, and a pound sign (#) indicates a significant
difference from 1 hr determined by one-way ANOVA followed by
Dunnett’s post hoc test for multiple comparison (n ¼ 6 from two
experiments).
GD ¼ glucose
deprivation;
LDH ¼ lactate
dehydrogenase;
ANOVA ¼ analysis of variance.

Discussion
Symptomatic hypoglycemia, resulting in brain dysfunction ranging from mild behavioral impairments to coma
(Wilson, 1983), is the principal problem associated with
tight glucose regulation in patients undergoing insulin
therapy (Amiel et al., 1987; Group, 1991; Cryer, 2001;
Griesdale et al., 2009). The idea that the underlying
cause of severe neurological complications that follow a
dangerous drop in blood glucose levels is not directly due
to substrate deprivation-induced energy failure has been
recognized since the early 1970s (for review, see Auer,
1986). Instead, the neuronal cell death that ensues
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occurs via excitotoxicity (Wieloch, 1985; Monyer and
Choi, 1988; Monyer et al., 1989; Papagapiou and Auer,
1990; Nellgard and Wieloch, 1992; Tasker et al., 1992;
Ichord et al., 2001; Jackman et al., 2012), the process of
which is most commonly ascribed to overexcitation of
neuronal glutamate receptors (Bo et al., 1994). While
multiple sources of glutamate could contribute to aglycemic neuron death (Danbolt, 2001), in vivo and in vitro
studies indicate a contributory role for neuronal exocytotic release of glutamate (Wieloch et al., 1985; Monyer
et al., 1989; Jackman et al., 2012) as well as an obligate
requirement for astrocytic system xc (Jackman et al.,
2012). The mechanism by which astrocytic system xc
contributes to aglycemic neuronal injury has been
explored in this study.
Using a mixed cortical cell culture system in vitro, we
demonstrated previously that enhancement of astrocyte
system xc (cystine/glutamate antiporter) expression and
activity facilitated by interleukin-1b contributed to the
development and progression of hypoxic neuronal
injury—a model of the ischemic penumbra (Fogal et al.,
2007; Jackman et al., 2010). While the enhanced extrusion of glutamate from astrocytic system xc activity was
not deleterious in and of itself, we found that under hypoxic conditions, astrocyte glutamate uptake was also
compromised, thus leading to glutamate buildup (Fogal
et al., 2007). Thus, we speculated that similar mechanisms
might be in play in our hypoglycemia model described
herein.
With respect to upregulation of system xc, we did ﬁnd
that xCT mRNA expression in astrocytes and mixed cultures was increased in a time-dependent manner following GD. However, in agreement with our previous study
(Jackman et al., 2012), a statistically signiﬁcant increase
did not occur in either culture system until 8 hr following
removal of glucose from the medium (Figure 3). Given
that much, if not all, of the death has already occurred by
this time point, it seems unlikely that a change in system
xc expression is necessary to mediate the deleterious
eﬀects of system xc under aglycemic conditions.
Indeed, actinomycin D or cycloheximide—used at concentrations shown previously by us to eﬀectively decrease
the transcriptional (10 mg/ml) and translational (1 mg/ml)
increases in astrocyte xCT facilitated by interleukin-1b,
respectively (Jackman et al., 2010)—failed to ameliorate
aglycemic neuronal injury (Figure 4). However, because
system xc transport can be enhanced via phosphorylation of putative protein kinase A sites in xCT (Baker
et al., 2002b) and changes in protein traﬃcking could
lead to changes in xCT protein insertion in the membrane
(Chase et al., 2013; Cramer and Chase, 2013; Ladd et al.,
2014), we also investigated the activity of system xc
activity using a radiolabeled cystine uptake assay. Our
results directly demonstrate that no change in system
xc activity occurs following GD (Figure 5(a)).
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Following release, the concentration of glutamate in
the extracellular space is carefully maintained at subtoxic
levels by its rapid reuptake. We initially surmised that
glucose-deprived astrocytes might show a diminution in
their ability to remove glutamate from the extracellular
space, thus leading to a toxic buildup. However,
using three diﬀerent assays—3H-D-asparte uptake
(Figure 5(b)), direct measurement of residual glutamate
levels in astrocyte media via HPLC following exogenous
addition of glutamate (Figure 6(a)), and a toxicity bioassay (Figure 6(b)) developed by our laboratory and validated for its ability to accurately reﬂect glutamate uptake
into astrocytes (Sen et al., 2011)—we demonstrate no
change in the ability of glucose-deprived astrocytes
alone or astrocytes contained in mixed culture to
remove glutamate from the extracellular environment.
While this might initially seem surprising, others have
shown that there were no changes in astrocytic glutamate
uptake in astrocytes for up to 2 hr of GD (Bakken et al.,
1998) and only a 20% loss after 24 hr (Swanson and
Benington, 1996). Indeed, unlike neurons (Auer et al.,
1984; Monyer and Choi, 1988; Monyer et al., 1989;
Goldberg and Choi, 1993), astrocytes have been demonstrated to be more resistant (Monyer and Choi, 1988;
Monyer et al., 1989; Goldberg and Choi, 1993; Lyons
and Kettenmann, 1998) to the ATP-depleting eﬀects of
glucose starvation by virtue of their ability to use glycogen stores (Cataldo and Broadwell, 1986; Swanson et al.,
1990) that can be metabolized to meet their metabolic
needs (Swanson et al., 1990; Erecinska and Silver, 1994;
Dienel and Cruz, 2006; Walls et al., 2009). In addition,
astrocytes can metabolize glutamate via the TCA cycle to
provide energy (Yu et al., 1982; Yu et al., 1984; McKenna
et al., 1996; McKenna, 2007), especially when glucose
levels are low (Bakken et al., 1998). Indeed, we found
that astrocytes are able to fully maintain their ATP
levels under the conditions of GD used in this study
(Figure 7(a)). Thus, the loss in mixed culture is then
likely due to changes in neuronal ATP production
(Figure 7(b)). These results are in good agreement with
what has been reported previously (Choi et al., 2008).
It is important to point out that neither enhanced
release of glutamate nor its diminished uptake may be
needed to facilitate excitotoxic neuronal cell death
under aglycemic conditions, as Novelli et al. demonstrated nearly 20 years ago that glutamate concentrations
needed to kill energy-deprived cerebellar neurons are far
less than those required to kill healthy neurons (Novelli
et al., 1988; Henneberry et al., 1989). These observations,
among others, led to the development of the weak excitotoxin hypothesis (Albin and Greenamyre, 1992), which
postulates that a reduction in cellular ATP leads to an
impairment in Naþ/Kþ ATPase activity resulting in a
slight membrane depolarization (Calabresi et al., 1997)
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that ultimately allows for voltage-dependent NMDA
receptors to be more easily activated (Henneberry et al.,
1989; Beal, 1992). Indeed, the reduction in neuronal
ATP correlated with the toxicity of glutamate
(Henneberry et al., 1989) and poisoning of the Naþ
pump with ouabain replicated what was found when
glucose was removed from the medium (Novelli et al.,
1988). In keeping with this hypothesis, we found
that glucose-deprived cultures showed a two- to threefold
enhancement in neuronal cell death when exposed
to 100mM glutamate at nearly every time point of GD
analyzed when compared with their glucosecontaining controls (Figure 8(a)). Similar results were
seen when NMDA was used (Figure 8(b)). As one
might expect, a longer therapeutic window of opportunity, at least when it comes to maximal or essentially full
protection, was achieved by blocking NMDA receptors when compared with blocking system xc itself,
although both drugs used showed signiﬁcant protection
up to a remarkable 5 hr following removal of glucose
(Figure 9).
Finally, the fact that system xc contributes to injury
might seem paradoxical given its importance in the biosynthesis of the antioxidant molecule glutathione
(Watanabe and Bannai, 1987; Bannai et al., 1989;
Miura et al., 1992; Sato et al., 1995; Bridges et al.,
2001; Dun et al., 2006; Lewerenz et al., 2009).
Ironically, while this pathway allows the CNS to rapidly
upregulate glutathione production in response to cellular
stress, we and others demonstrate its potential to exacerbate CNS pathology both in vitro and in vivo (for reviews,
see Bridges et al., 2012; Lewerenz et al., 2013; Massie
et al., 2015). As such, it is becoming increasingly clear
that the consequences of system xc activity are complex
and context-dependent. Hence, system xc activity can
either be beneﬁcial (Tanaka et al., 1999; Shih et al.,
2003; Jakel et al., 2007; He et al., 2015) or can contribute
to pathophysiology (Piani and Fontana, 1994; Ye et al.,
1999; Barger and Basile, 2001; Qin et al., 2006; Fogal
et al., 2007; Savaskan et al., 2008; Sontheimer, 2008;
Jackman et al., 2010; Massie et al., 2011; Jackman
et al., 2012), the ultimate eﬀect being dependent on the
environmental and cellular milieu.
In sum, we ﬁnd that aglycemic neuronal cell death
does not result from changes in astrocyte system xc
expression or activity or from impairment of glutamate
removal. Instead, our results are consistent with the weak
excitotoxic hypothesis (Albin and Greenamyre, 1992),
suggesting that the bioenergetic deﬁciencies, which are
present in our mixed cultures, enhance the toxic eﬀect
of physiological levels of glutamate released from astrocyte system xc. Whether system xc plays a similar role
in hypoglycemic neurodegeneration in vivo requires further experimentation.
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